Wenzhou Kangning Hospital Co., Ltd.

HKSE 2120.HK

Wenzhou Kangning Hospital Co., Ltd. Revenue Per Share for the year ending December 31, 2023: USD 3.01

Wenzhou Kangning Hospital Co., Ltd. Revenue Per Share is USD 3.01 for the year ending December 31, 2023, a 4.49% change year over year. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
  • Wenzhou Kangning Hospital Co., Ltd. Revenue Per Share for the year ending December 31, 2022 was USD 2.88, a 1.91% change year over year.
  • Wenzhou Kangning Hospital Co., Ltd. Revenue Per Share for the year ending December 31, 2021 was USD 2.83, a 29.80% change year over year.
  • Wenzhou Kangning Hospital Co., Ltd. Revenue Per Share for the year ending December 31, 2020 was USD 2.18, a 28.87% change year over year.
  • Wenzhou Kangning Hospital Co., Ltd. Revenue Per Share for the year ending December 31, 2019 was USD 1.69, a 13.95% change year over year.
Key data
Date Revenue Per Share Dividend Per Share Free Cash Flow Per Share Return on Assets (ROA)
Market news
Loading...
HKSE: 2120.HK

Wenzhou Kangning Hospital Co., Ltd.

CEO Mr. Weili Guan
IPO Date Nov. 20, 2015
Location China
Headquarters No.1 Shengjin Road
Employees 4,742
Sector Health Care
Industries
Description

Wenzhou Kangning Hospital Co., Ltd. operates and manages a network of healthcare facilities in the People's Republic of China. It primarily focuses on providing psychiatric specialty care. The company also provides property leasing and sale services; and software and information technology services, as well as hospital management, forensic authentication, and medical services. It is also engaged in pharmaceutical retail. The company was formerly known as Wenzhou City Kangning Psychiatric Rehabilitation Hospital and changed its name to Wenzhou Kangning Hospital Co., Ltd. in October 2014. Wenzhou Kangning Hospital Co., Ltd. was founded in 1996 and is headquartered in Wenzhou, the People's Republic of China.

StockViz Staff

January 15, 2025

Any question? Send us an email